883 related articles for article (PubMed ID: 20817886)
1. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
2. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
Maurer T
Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
[TBL] [Abstract][Full Text] [Related]
3. From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance.
Giannetti AM
Methods Enzymol; 2011; 493():169-218. PubMed ID: 21371592
[TBL] [Abstract][Full Text] [Related]
4. Experiences in fragment-based lead discovery.
Hubbard RE; Murray JB
Methods Enzymol; 2011; 493():509-31. PubMed ID: 21371604
[TBL] [Abstract][Full Text] [Related]
5. Effective progression of nuclear magnetic resonance-detected fragment hits.
Eaton HL; Wyss DF
Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
[TBL] [Abstract][Full Text] [Related]
6. Practical aspects of NMR-based fragment screening.
Lepre CA
Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
[TBL] [Abstract][Full Text] [Related]
7. NMR screening in fragment-based drug design: a practical guide.
Kim HY; Wyss DF
Methods Mol Biol; 2015; 1263():197-208. PubMed ID: 25618347
[TBL] [Abstract][Full Text] [Related]
8. Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?
Wielens J; Headey SJ; Rhodes DI; Mulder RJ; Dolezal O; Deadman JJ; Newman J; Chalmers DK; Parker MW; Peat TS; Scanlon MJ
J Biomol Screen; 2013 Feb; 18(2):147-59. PubMed ID: 23139382
[TBL] [Abstract][Full Text] [Related]
9. Experimental validation of a fragment library for lead discovery using SPR biosensor technology.
Elinder M; Geitmann M; Gossas T; Källblad P; Winquist J; Nordström H; Hämäläinen M; Danielson UH
J Biomol Screen; 2011 Jan; 16(1):15-25. PubMed ID: 21149860
[TBL] [Abstract][Full Text] [Related]
10. Integrating surface plasmon resonance biosensor-based interaction kinetic analyses into the lead discovery and optimization process.
Danielson UH
Future Med Chem; 2009 Nov; 1(8):1399-414. PubMed ID: 21426056
[TBL] [Abstract][Full Text] [Related]
11. TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery.
Vanwetswinkel S; Heetebrij RJ; van Duynhoven J; Hollander JG; Filippov DV; Hajduk PJ; Siegal G
Chem Biol; 2005 Feb; 12(2):207-16. PubMed ID: 15734648
[TBL] [Abstract][Full Text] [Related]
12. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine.
Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C
J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332
[TBL] [Abstract][Full Text] [Related]
13. SPR-based fragment screening: advantages and applications.
Neumann T; Junker HD; Schmidt K; Sekul R
Curr Top Med Chem; 2007; 7(16):1630-42. PubMed ID: 17979772
[TBL] [Abstract][Full Text] [Related]
14. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
Hennig M; Ruf A; Huber W
Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
[TBL] [Abstract][Full Text] [Related]
15. [NMR in the fragment-based drug discovery].
Hanzawa H; Takizawa T
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
[No Abstract] [Full Text] [Related]
16. A SPR strategy for high-throughput ligand screenings based on synthetic peptides mimicking a selected subdomain of the target protein: a proof of concept on HER2 receptor.
Monfregola L; Vitale RM; Amodeo P; De Luca S
Bioorg Med Chem; 2009 Oct; 17(19):7015-20. PubMed ID: 19733086
[TBL] [Abstract][Full Text] [Related]
17. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
Wyss DF; Wang YS; Eaton HL; Strickland C; Voigt JH; Zhu Z; Stamford AW
Top Curr Chem; 2012; 317():83-114. PubMed ID: 21647837
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Kinase Production and Fragment Screening by NMR Spectroscopy.
Han B; Ahn HC
Methods Mol Biol; 2016; 1360():35-46. PubMed ID: 26501900
[TBL] [Abstract][Full Text] [Related]
19. Label free fragment screening using surface plasmon resonance as a tool for fragment finding - analyzing parkin, a difficult CNS target.
Regnström K; Yan J; Nguyen L; Callaway K; Yang Y; Diep L; Xing W; Adhikari A; Beroza P; Hom RK; Riley B; Rudolph D; Jobling MF; Baker J; Johnston J; Konradi A; Bova MP; Artis DR
PLoS One; 2013; 8(7):e66879. PubMed ID: 23861750
[TBL] [Abstract][Full Text] [Related]
20. Saturation transfer difference NMR for fragment screening.
Begley DW; Moen SO; Pierce PG; Zartler ER
Curr Protoc Chem Biol; 2013; 5(4):251-268. PubMed ID: 24391096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]